Leading Pharmaceutical Innovation: Trends and Drivers for Growth in the Pharmaceutical Industry - Tapa dura

Gassmann, Oliver; Reepmeyer, Gerrit; Zedtwitz, Maximilian Von

 
9783540407171: Leading Pharmaceutical Innovation: Trends and Drivers for Growth in the Pharmaceutical Industry
Tapa dura
ISBN 10: 3540407170 ISBN 13: 9783540407171
Editorial: Springer-Verlag Berlin and Heidelberg GmbH & Co. K, 2004

Sinopsis

The pharmaceutical industry is in a dire situation: R&D still produces no more drugs than 10 years ago, while costs have quadrupled in the meantime. Little advances have been made in innovation efficiency. Worse yet, drug development times are unacceptably long, possible drug development targets are waning, and national healthcare is tightening the cost squeeze. A predictable and efficient pipeline of drug candidates, coupled with a handful of blockbuster drugs, is considered the Holy Grail of pharmaceutical innovation. In this book, the authors develop a case for mastering pharmaceutical innovation focusing on three leading sources of future pharmaceutical competitiveness: new technologies and techniques, better pipeline management, and stronger integration of external innovation. Illustrated with plenty of real-life cases, this book tells you how to put the principles of leading pharmaceutical innovation into practice.

"Sinopsis" puede pertenecer a otra edición de este libro.

Críticas

From the reviews: "This book examines the international pharmaceutical industry with special emphasis on the current and emerging research methodologies a ] . What distinguishes this book from others on the same subject is its emphasis on empirical findings (53 figures, 20 tables) and an exceptionally good, if short, discussion of various research technologies a ] . The six-page glossary of industry terms, when used with its decent index, is a particular joy. a ] recommend this offering to prospective managers and researchers in this industry a ] ." (Robert R. Rothberg, Journal of Product Innovation Management, Vol. 22, 2005)

Reseña del editor

Pharmaceutical giants have been doubling their investments in drug development, only to see new drug approvals to remain constant for the past decade. This book investigates and highlights a set of proactive strategies. The authors focus on three sources of pharmaceutical innovation: new management methods, new technologies, and new forms of internationalization. Their findings are illustrated in the case of the Swiss pharmaceutical industry, the leading exporter of pharmaceutical products in percentage of GDP, and some of its main pharmaceutical firms such as Novartis and Hoffmann-La Roche.

"Sobre este título" puede pertenecer a otra edición de este libro.

Editorial
Springer-Verlag Berlin and Heidelberg GmbH & Co. K
Año de publicación
2004
Idioma
Inglés
ISBN 10 
3540407170
ISBN 13 
9783540407171
Encuadernación
Tapa dura
Número de páginas
189
Contacto del fabricante
no disponible
Persona responsable
CMN Printpool Inh. Mathis Neumann
https://www.also.com/ec/cms5/en_6000/6000/index.jsp

Friedrich-Karl-Str. 9
Hamburg
Alemania

Otras ediciones populares con el mismo título

9783642096389: Leading Pharmaceutical Innovation: Trends and Drivers for Growth in the Pharmaceutical Industry

Edición Destacada

ISBN 10:  3642096387 ISBN 13:  9783642096389
Editorial: Springer, 2009
Tapa blanda